NEW YORK ( TheStreet) -- Shares of Taylor Devices (Nasdaq: TAYD) have taken a tremendous swing upward. The stock is trading at $9.44 as of 11:20 a.m. ET, 22.1% above Wednesday's closing price of $7.73. Volume is at 94,160, 11.9 times the daily average of 7,900. Taylor Devices has a market cap of $25.7 million and is part of the industrial goods sector and industrial industry. Shares are up 0.1% year to date as of the close of trading on Wednesday. Taylor Devices, Inc. engages in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company has a P/E ratio of 15.4, above the average industrial industry P/E ratio of 15.3 and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Taylor Devices as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Taylor Devices Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center. Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Markets
Stocks Retreat After Record Closings for S&P 500 and Nasdaq
Stocks trade lower Wednesday, a day after the S&P 500 and the Nasdaq set new closing records.
Biogen Shares Fall After Drugmaker Meets Earnings Estimates
The stock dips after the drugmaker beats quarterly revenue estimates and earnings meet forecasts.
Target These Underperformers in Asian 'Goldilocks' Phase
Key drivers of this 'just right' phase, and how to play it.